These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 8172347)
21. [The vascular effects of estrogens and the hormonal replacement therapy of climacteric disorders]. Shvarts GIa Eksp Klin Farmakol; 1996; 59(6):62-9. PubMed ID: 9181880 [No Abstract] [Full Text] [Related]
22. [Psychometric aspects of estrogen therapy in the climacteric. Quantification of the psychotropic effect of hormones in 122 women (author's transl)]. Wenderlein JM MMW Munch Med Wochenschr; 1980 Mar; 122(12):419-22. PubMed ID: 6769003 [TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis. Chollet JA; Carter G; Meyn LA; Mermelstein F; Balk JL Menopause; 2009; 16(5):978-83. PubMed ID: 19390463 [TBL] [Abstract][Full Text] [Related]
25. [Clinical and laboratory evaluation of the preparation Synapause]. Pilawski Z; Flizikowska G; Zółtowski M; Olszewska D; Kosmowska B; Sych Z Ginekol Pol; 1982; 53(11):821-6. PubMed ID: 7184808 [No Abstract] [Full Text] [Related]
27. [Oral hormone therapy in pre- and postmenopause]. Braendle W Med Klin (Munich); 1990 Apr; 85(4):200-5. PubMed ID: 2191210 [No Abstract] [Full Text] [Related]
28. [Pro and contra hormonal substitution in the climacteric]. Vesper B Gynakol Rundsch; 1988; 28 Suppl 2():175-8. PubMed ID: 3234914 [No Abstract] [Full Text] [Related]
29. [Principles of hormonal therapy in menopause]. Maleeva A Akush Ginekol (Sofiia); 1989; 28(4):78-84. PubMed ID: 2679195 [No Abstract] [Full Text] [Related]
37. [Oral hormone therapy in the pre- and postmenopausal period]. Braendle W; Bettendorf G Gynakologe; 1986 Dec; 19(4):235-40. PubMed ID: 3817595 [No Abstract] [Full Text] [Related]
38. [New preparations for treatment of climacterial disorders]. Nesheim BI Tidsskr Nor Laegeforen; 1979 May; 99(15):792-3. PubMed ID: 462446 [TBL] [Abstract][Full Text] [Related]
39. [Hormone therapy and the risk of cancer in the climacteric]. Kuhl H; Taubert HD Gynakologe; 1986 Dec; 19(4):259-65. PubMed ID: 3817599 [No Abstract] [Full Text] [Related]
40. The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy? Holtorf K Postgrad Med; 2009 Jan; 121(1):73-85. PubMed ID: 19179815 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]